Displaying 41 to 60 of 64 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Methylgene Inc Clinical-stage biopharmaceutical company that develops novel therapeutics for cancer and infectious disease. |
Canada | N/A Active |
||
|
|
Milestone Pharmaceuticals Inc Drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. |
Canada | N/A Active |
||
|
|
Nereus Pharmaceuticals Inc |
United States | N/A |
||
|
|
NuVasive Inc |
United States | N/A |
||
|
|
Nuvelo Inc Optimize therapeutic outcomes for patients and their prescribing physicians. |
United States | N/A |
||
|
|
Optherion Inc |
United States | N/A |
||
|
|
Panacos Pharmaceuticals Inc |
United States | N/A |
||
|
|
Peninsula Pharmaceuticals Inc |
United States | N/A |
||
|
|
Plexigen Diagnostic company focusing on instrumentation and service for a wide array of clinical testing. |
United States | N/A |
||
|
|
Plexxikon Inc |
United States | N/A |
||
|
|
Reprogenesis A public company focused on regenerative medicine. |
United States | N/A |
||
|
|
Selventa Inc A personalized healthcare company helping pharmaceutical and biotechnology partners find optimal treatments for the right patients. |
United States | N/A |
||
|
|
Sensys Medical |
United States | N/A |
||
|
|
Signase |
United States | N/A |
||
|
|
Spherics Inc Pharmaceutical company focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles. |
United States | N/A |
||
|
|
Syndax Pharmaceuticals Inc A clinical development company focused on novel oral therapies for cancer. |
United States | N/A |
||
|
|
Syntonix Pharmaceuticals Inc A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into |
United States | N/A |
||
|
|
TargeGen Inc |
United States | N/A Active |
||
|
|
TESARO Inc |
United States | N/A |
||
|
|
TyRx Inc |
United States | 1 Dec 2010 | N/A |